Blocking therapy in headaches
Delfino, U.
Minerva Medica 73(12): 681-688
1982
ISSN/ISBN: 0026-4806 PMID: 7063128 Document Number: 194921
Document emailed within 1 workday
Related Documents
Chappon, C. 1978: Therapy of headaches. Apropos of 87 cases La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 54(25-28): 821-823Bokonjić, R. 1988: Present knowledge of pathogenesis, pathophysiology, clinical aspects and therapy of vascular headaches Neurologija 37(3-4): 83-104
2000: 6th Congress of Therapy and Neurology: Headaches. Paris, France, 3-4 December 1999. Proceedings Revue Neurologique (Paris) 156(Suppl 4): 4s4-112
Zharkovskiĭ, A.M.; Langel, I.L.; Chereshka, K.S.; Zharkovskaia, T.A. 1987: Significance of the dopamine-blocking and m-choline-blocking components in the antiapomorphine action of neuroleptics Biulleten' Eksperimental'noi Biologii i Meditsiny 103(3): 317-319
Erikssen, J. 1970: Beta-adrenergic blocking therapy in thyrotoxicosis Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 90(11): 1206-1210
2003: Aldosterone blocking -- a rediscovered therapy principle MMW Fortschritte der Medizin 145(44): 43
Huang, Y.-y.; Hu, K.-h. 2014: New Strategy for anti-HBV therapy: blocking P-8 interaction Bing du Xue Bao 30(6): 713-720
Yamamoto, N.; Nomura, M.; Okubo, K.; Maeda, K.; Goto, T. 1999: Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent Journal of Cardiovascular Pharmacology 33(4): 587-594
Gromkowski, S.H.; Heagy, W.; Sanchez-Madrid, F.; Springer, T.A.; Martz, E. 1983: Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and LYT-2,3. I. Increased susceptibility to blocking after papain treatment of target cells Journal of Immunology 130(6): 2546-2551
Asano, M.; Uchida, W.; Shibasaki, K.; Terai, M.; Inagaki, O.; Takenaka, T.; Matsumoto, Y.; Fujikura, T. 1990: Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agent Journal of Pharmacology and Experimental Therapeutics 254(1): 204-211
Repetto, S.; Cozzi, A.; Forgione, N.; Verna, E.; Binaghi, G. 1979: Beta-blocking therapy in the acute phase of myocardial infarct Bollettino Della Societa Italiana di Cardiologia 24(8): 866
Chalmers, J.; Wing, L.; West, M.; Bune, A.; Johnston, C.; Jackson, B.; McGrath, B.; Mashford, M.L.; Heath, W.; Westwood, B. 1987: Felodipine compared to prazosin as additional therapy to a beta-blocking drug Journal of Cardiovascular Pharmacology 10(Suppl 10): S82-S84
Fedotov, V.P. 1985: Blocking action of the serum of patients with rubromycosis after different methods of differentiated therapy Vestnik Dermatologii i Venerologii 12: 18-22
Schenk, G.K.; Lang, E.; Anlauf, M. 1981: Beta-receptor blocking therapy in hypertensive patients--effects on vigilance and behaviour Aviation Space and Environmental Medicine 52(11 Part 2): S35-S39
Kirch, W.; Von Gizycki, C. 1980: Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances International Journal of Clinical Pharmacology Therapy and Toxicology 18(5): 233-235
Miyagishi, A.; Nakahara, H.; Hara, Y. 1984: Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent Archives Internationales de Pharmacodynamie et de Therapie 271(2): 249-262
Krikler, D.M. 1988: Uses of calcium channel blocking agents and beta blocking agents in the control of supraventricular arrhythmias Progress in Clinical and Biological Research 275: 301-317
Schulte, K.L.; Meyer-Sabellek, W.; Thiede, H.M.; Röcker, L.; Gotzen, R. 1987: Beta-adrenoceptor stimulating and blocking agents in essential hypertension: single and combined therapy with terbutaline and metoprolol International Journal of Clinical Pharmacology Therapy and Toxicology 25(10): 539-544
Gabrielli, G.; Salvi, W.; Scambia, L.; Fiorani, S. 1979: Critical evaluation of the use of beta-blocking agents in the treatment of acute myocardial infarct in intensive therapy and resuscitation La Clinica Terapeutica 88(2): 159-171
1979: Adverse Drug Reactions Advisory Committee. Peyronie's disease. A complication in therapy with beta-adrenoreceptor blocking drugs? Medical Journal of Australia 2(8): 432